Cargando…
Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy
BACKGROUND: Ischemia/reperfusion (I/R) injury causes the generation of many ROS such as H(2)O(2) and leads to vascular thrombosis, which causes tissue damage. PURPOSE: In this investigation, poly (lactideco-glycolide) (PLGA)-based nanoparticles are used for their anticoagulant and antioxidant proper...
Autores principales: | Lee, Pei-Chi, Zan, Bo-Shen, Chen, Li-Ting, Chung, Tze-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396665/ https://www.ncbi.nlm.nih.gov/pubmed/30880963 http://dx.doi.org/10.2147/IJN.S174962 |
Ejemplares similares
-
Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
por: Lu, Boting, et al.
Publicado: (2019) -
Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018) -
Multifunctional Polymer Nanoparticles for Dual Drug Release and Cancer Cell Targeting
por: Wen, Yu-Han, et al.
Publicado: (2017) -
Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
por: Patel, Bhavin K, et al.
Publicado: (2018) -
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
por: Cunha, Anthony, et al.
Publicado: (2021)